Brussels   |     |   Public conference

New world order: Science, technology & trade

A Science|Business public conference


The world is changing fast. Will technology trade barriers rise? Will relations among Europe, the US, China, Russia and other powers be upended? Will research priorities change – for climate, energy, health, defence? All of these questions will force new strategies for companies, universities and governments around the world.

The annual Science|Business Network conference will focus on how international relations in science, technology and trade could be transformed – and how these changes will, in turn, affect the EU’s next flagship R&D effort, Framework Programme 9.

Programme

09:00 - Welcome, by Richard Hudson, Editor-in-chief and Vice Chair of the Board, Science|Business

09:05 - The new world order: What it means for research and innovation

  • Jean Chambaz, President, Pierre and Marie Curie University
  • Christian Leffler, Deputy Secretary General, European External Action Service
  • Joanna Newman, Secretary General, The Association of Commonwealth Universities
  • Maria Fernanda Rollo, Secretary of State for Science, Technology and Higher Education, Government of Portugal
  • Walter Weigel, Vice President, Huawei European Research Institute

Moderated by Richard L. Hudson, Editor-in-chief and Vice Chair of the Board, Science|Business

10:00 - Keynote speech, by Jyrki Katainen, Vice-President for Jobs, Growth, Investment and Competitiveness, European Commission

10:30 - The impact on the next Framework Programme. Launch of the Science|Business report: “Why fund research?”

Q&A with Robert-Jan Smits, Director-General for Research and Innovation, European Commission

11:00 - Coffee

11:30 - Parallel sessions: What the new world order means for …

A deep dive into three sector-specific issues that are both changed by the new world order, and have the potential to change it for the better.

  • Healthcare: Infectious diseases and vaccines research. The Ebola crisis was a wake-up call for international cooperation.
    • Heidi Larson, Director of The Vaccine Confidence Project (VCP); Professor, Department of Infectious Disease Epidemiology, LSHTM
    • Jean Lang, Associate Vice President R&D, Sanofi Pasteur
    • Xavier Prats Monné, Director-General for Health and Food Safety, European Commission
    • Heinz-Josef Schmitt, Senior Director Pfizer Vaccines; Head (European Union) Vaccines Medicines Development Group and Scientific Affairs, Pfizer

Moderated by Monica Dietl, Senior Advisor, Science|Business

  • Climate & Energy. If the US is out of the picture, what next for climate and renewable energy research?
    • Patrick Child, Deputy Director-General, DG Research and Innovation, European Commission
    • Jill Duggan, Director of Policy, Cambridge Institute for Sustainability Leadership; Director, Prince of Wales's Corporate Leaders Group (CLG)
    • Philippe Tanguy, VP R&D Partnerships, Total

Moderated by Eric Drosin, Director of Strategic Development and Communications, Science|Business

  • Cyber Security: After Wanna Cry can we ever feel safe online again?
    • Edit Herczog, Managing Director, Vision & Values SPRL; Member, RDA World Council
    • Olav Lysne, Professor, University of Oslo; Section Director, Simula Research Laboratory, University of Oslo
    • Fabio Martinelli, First Director of the Board, European Cyber Security Organisation
    • Bryan Roeten, COO, CopSonic
    • Marietje Schaake, Member, European Parliament (video message)

Moderated by David Pringle, Senior Advisor, Science|Business

12:30 - Lunch

13:30 - Global disruptors (and creators): Projects that can make a difference

Research and innovation are about a lot more than gadgets and medicines; they can provide entirely new ways to solve old problems. Four visionary examples.

  • The immunology of Alzheimer’s - Michal Schwartz,Professor of Neuroimmunology, Weizmann Institute of Science
  • The open science revolution - Kamila Markram, CEO, Frontiers - Open Science Platform
  • Science as diplomacy: PRIMA in the Mediterranean - Angelo Riccaboni, Chair, PRIMA Foundation
  • The Innovation Bank – Andre Lee, Founder, Snowflake Innovations; Founder, CEO, Technology Reserve

Moderated by Richard Hudson, Editor-in-chief and Vice Chair of the Board, Science|Business

14:30 - Breakouts: Making international research collaboration work

Some projects only make sense in an international context. Workshops to examine a few.

  • The Cloud. Despite tensions, there really is growing cross-border collaboration on making the cloud work for science. The EU is promoting its science cloud. It, the US, Canada and Australia are promoting data sharing. (Session organised by the Science|Business Cloud Consultation Group)
    • Brendan Bouffler, Head of Amazon Web Services' Research Cloud Program, Amazon
    • Jean-Claude Burgelman, Head of Unit, DG Research & Innovation, European Commission
    • Bob Jones, Coordinator, Helix Nebula, CERN
    • Jukka Mönkkönen, Rector, University of Eastern Finland

Moderated by David Pringle, Senior Advisor, Science|Business

  • Blue money: Case studies in international maritime innovation. Autonomous shipping, wireless ports – these and other maritime innovations are appearing around the world, in public/private collaborations from the Artic to Antarctic. This session examines a few case studies, and asks: How can we scale these up globally? (sponsored by Tekes)
    • Gunnar Brink, Project Lead, ARGGONAUTS -a Shell Ocean Discovery XPRIZE team-, Fraunhofer IOSB
    • John Bell, Director for Bioeconomy, DG Research and Innovation, European Commission
    • Amleto Gabellone, Programme Manager, Centre for Maritime Research and Experimentation, NATO S&T Organisation
    • Mika Lautanala, Executive Director, Tekes
    • Mervi Pitkänen, Head of External Funding, Innovation & Technology, Rolls-Royce Marine

Moderated by Maryline Fiaschi, Managing Director, Science|Business

  • New finance models: Bridging the gap from science to start-up. Around the world, financing science-based companies is difficult. A panel looks at a range of models for this, including the ATTRACT Consortium of research infrastructure (sponsored by ATTRACT)
    • Uffe Bundgård-Jørgensen, CEO, InvestorNet
    • Candace Johnson, President, European Business Angels Network (EBAN)
    • Steve Rogers, Deputy Head of Unit, SMEs, Financial Instruments and State Aid, European Commission
    • Wim Vanhaverbeke, Professor Strategy and Innovation Management, University of Hasselt
    • Michael Willmott, First Secretary, Science and Technology; Trade, Investment and S&T Section, Mission of Canada to the EU

Moderated by John Wood, Chair, ATTRACT Project Advisory Committee

15:30 - Coffee

16:00 - Getting real: How can the Framework Programme make international collaboration happen?

Let’s talk specifics: How can EU R&I programmes enlist more international partners, and magnify their international impact?

  • Presentation of the H2020 international ‘flagships’
    • Maria Cristina Russo, Director for International Cooperation, DG Research and Innovation, European Commission
  • Science|Business Network Report: Recommendations for international collaboration
    • Abdelhamid El-Zoheiry, President, Euro-Mediterranean University (EMUNI)
    • Sonia Ortega, Head of Europe Office, US National Science Foundation
    • Vinny Pillay, Minister Counsellor, Mission of South Africa to the EU, South African Department of Science & Technology
    • Maria Cristina Russo, Director for International Cooperation, DG Research and Innovation, European Commission
    • Heinz-Josef Schmitt, Senior Director Pfizer Vaccines; Head (European Union) Vaccines Medicines Development Group and Scientific Affairs, Pfizer

Moderated by Maryline Fiaschi, Managing Director, Science|Business

 

17:15 - Reception

Speakers
Jyrki Katainen
Vice-President for Jobs, Growth, Investment and Competitiveness, European Commission
Maria Fernanda Rollo
Secretary of State of Science, Techonology and Higher Education, Government of Portugal
Robert-Jan Smits
Director-General, DG Research & Innovation, European Commission
Kamila Markram
CEO, Frontiers - Open Science Platform
Xavier Prats Monné
Director General, DG SANTE, European Commission
Joanna Newman
Secretary General, The Association of Commonwealth Universities
Jean Chambaz
President, Pierre and Marie Curie University
Jean Lang
Associate Vice President R&D, Sanofi Pasteur
Maria Cristina Russo
Director, International Cooperation, DG RTD, European Commission
Jukka Mönkkönen
Rector, University of Eastern Finland
Sonia Ortega
Head of Europe Office, US National Science Foundation
Philippe Tanguy
Vice President R&D Partnerships, Total
Heidi Larson
Director of The Vaccine Confidence Project (VCP); Professor, Department of Infectious Disease Epidemiology, LSHTM
Patrick Child
Deputy Director General, DG Research & Innovation, European Commission
Michal Schwartz
Professor of Neuroimmunology, incumbent of The Maurice and Ilse Katz Professorial Chair in Neuroimmunology, Weizmann Institute of Science
Angelo Riccaboni
President, Prima Foundation
Candace Johnson
President, European Business Angels Network (EBAN)
Jean-Claude Burgelman
Head of Unit, Science Policy and Foresight, DG RTD, European Commission
Mervi Pitkänen
Head of External Funding, Innovation & Technology, Marine, Rolls-Royce
John Bell
Director for Bioeconomy, DG Research and Innovation, European Commission
Abdelhamid ElZoheiry
President, EMUNI University
Contact

For further information, please contact Isabel Ortega at isabel.ortega@sciencebusiness.net

To know more about partnership options, please contact Maryline Fiaschi at maryline.fiaschi@sciencebusiness.net

Partners